IPSC — Century Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Century Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	75.8	223	315	173	189
Net Total Receivables	—	—	—	—	1.52
Prepaid Expenses
Total Other Current Assets
Total Current Assets	78.8	228	320	177	194
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.8	69.8	112	92.1	90.8
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	107	437	487	361	353
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.1	15.7	29.8	17.8	130
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	33.4	41.1	184	176	192
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	73.3	396	303	185	161
Total Liabilities & Shareholders' Equity	107	437	487	361	353
Total Common Shares Outstanding